RABEPRAZOLE EC
SANIS HEALTH INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of RABEPRAZOLE EC in Canada?
A shortage of RABEPRAZOLE EC 20MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 14, 2026), but it has not started yet.
Why is RABEPRAZOLE EC not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will RABEPRAZOLE EC be available again?
The manufacturer's estimated resolution date is October 9, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Proton Pump Inhibitor (PPI) Shortage in Canada: Omeprazole, Pantoprazole, Rabeprazole
Why a shortage of one PPI brand rarely means the whole class is unavailable, when a pharmacist can swap manufacturers, and when it needs your prescriber.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
RABEPRAZOLE EC
MELIAPHARM INC
TARO-RABEPRAZOLE
SUN PHARMA CANADA INC
DOM-RABEPRAZOLE EC
DOMINION PHARMACAL
Other Products
ABBOTT-RABEPRAZOLE
BGP PHARMA ULC
NTP-RABEPRAZOLE EC
NT PHARMA CANADA LTD
PARIET, ENTERIC-COATED TABLET 10MG
JANSSEN INC
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
Estimated Resolution
2026-10-09
~11 days remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02356538
Strength
20MG
Dosage Form
TABLET (ENTERIC-COATED)
Route
ORAL
Active Ingredient
RABEPRAZOLE SODIUM
Tier
Unrated
Last Updated
2026-09-14
Reason for Shortage
Disruption of the manufacture of the drug.
Other Products from SANIS HEALTH INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02286254
400MG · DIN 02286262
100MG · DIN 02286246
400MG · DIN 02286564
70MG · DIN 02352966
10MG · DIN 02519844
12.5MG · DIN 02466821
0.50MG · DIN 02349205
0.25MG · DIN 02349191
200MG · DIN 02364336
10MG · DIN 02331292
5MG · DIN 02331284